Conclusions In conclusion, our study provides compelling preclinical evidence that low dose semaglutide, at levels that do not induce significant weight loss, exerts substantial beneficial effects in an animal model of cardiometabolic HFpEF
Thats exactly what new research from Israel is pointing to, and it has doctors and scientists buzzing
Include healthy fats in small portions to stimulate regular gallbladder emptying
On 14 January 2026, the General Pharmaceutical Council published an updated inspection framework, including specific guidance relating to weight-loss medications, online pharmacies, prescribing and incentives
Wednesday Strength training (40-45 minutes)
B-12 Lipo-Plus injections are a safe option when given by a trained healthcare provider